Angiotensin- neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure?

被引：0
|
作者：
Grigg, Sam E. [1 ]
机构：
[1] Austin Hlth, Dept Med, Heidelberg, Vic, Australia
来源：
BMJ EVIDENCE-BASED MEDICINE | 2020年 / 25卷 / 04期
关键词：
GUIDELINES;
D O I：
10.1136/bmjebm-2019-111260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [1] Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure
    Velazquez, Eric J.
    Morrow, David A.
    DeVore, Adam D.
    Duffy, Carol I.
    Ambrosy, Andrew P.
    McCague, Kevin
    Rocha, Ricardo
    Braunwald, Eugene
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 539 - 548
  • [2] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Sharma, Aditya
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (04) : 208 - 208
  • [3] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
    Badwan, Osamah Z.
    Braghieri, Lorenzo
    Skoza, Warren
    Agrawal, Ankit
    Menon, Venu
    Tang, W. H. Wilson
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (01) : 47 - 51
  • [4] Effect of Angiotensin Receptor-neprilysin Inhibitor on Acute Kidney Injury in Patients With Acute Decompensated Heart Failure
    Li, Gonghao
    Zhao, Yanli
    Peng, Zhongxing
    Liu, Kun
    Yin, Delu
    Zhao, Yunfeng
    CARDIOLOGY DISCOVERY, 2024, 4 (01): : 23 - 29
  • [5] Angiotensin receptor neprilysin inhibitors in older patients with heart failure
    Sharkey, Anthony T.
    Ghafar, Mohd Zaquan
    O'Keeffe, Shaun T.
    Mulkerrin, Eamon C.
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (01) : 5 - 7
  • [6] When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure? Reply
    Badwan, Osamah Z.
    Menon, Venu
    Tang, W. H. Wilson
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (04) : 207 - 208
  • [7] Safety and feasibility of angiotensin receptor neprilysin inhibitor in real-world patients with acute decompensated heart failure
    Rossini, Roberta
    Angelini, Filippo
    Giordana, Francesca
    Coppini, Lucia
    Ferraro, Ilenia
    Ruffino, Enrico
    Varbella, Ferdinando
    Tizzani, Emanuele
    Valente, Eduardo
    Musumeci, Giuseppe
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (03) : 266 - 274
  • [8] Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
    Ntalianis, Argyrios
    Chrysohoou, Christina
    Giannakoulas, George
    Giamouzis, Grigorios
    Karavidas, Apostolos
    Naka, Aikaterini
    Papadopoulos, Constantinos H.
    Patsilinakos, Sotirios
    Parissis, John
    Tziakas, Dimitrios
    Kanakakis, John
    HEART FAILURE REVIEWS, 2022, 27 (01) : 1 - 13
  • [9] Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
    Argyrios Ntalianis
    Christina Chrysohoou
    George Giannakoulas
    Grigorios Giamouzis
    Apostolos Karavidas
    Aikaterini Naka
    Constantinos H. Papadopoulos
    Sotirios Patsilinakos
    John Parissis
    Dimitrios Tziakas
    John Kanakakis
    Heart Failure Reviews, 2022, 27 : 1 - 13
  • [10] Should we continue beta-blocker in acute decompensated heart failure patients?
    Adda'i, M. F.
    Kusmanto, V. B.
    Haposan, J. H.
    Setyani, A. B.
    Dewi, I. P.
    Abduh, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0E) : E73 - E73
12345